PubRank

J P H Drenth

Author PubWeight™ 50.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Value of molecular analysis of Wilson's disease in the absence of tissue copper deposits: a novel ATP7B mutation in an adult patient. Neth J Med 2008 1.77
2 Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability. Neurology 2012 1.73
3 NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci 2008 1.70
4 Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63. Clin Genet 2010 1.55
5 Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 2005 1.48
6 The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes. Aliment Pharmacol Ther 2011 1.42
7 Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther 2012 1.27
8 Somatostatin analogues reduce liver volume in polycystic liver disease. Gut 2008 1.25
9 The long-term outcome of patients with polycystic liver disease treated with lanreotide. Aliment Pharmacol Ther 2011 1.17
10 Glycogenic hepatopathy: a rare cause of elevated serum transaminases in diabetes mellitus. Neth J Med 2009 1.15
11 Pharmacological management of pain in chronic pancreatitis. Dig Liver Dis 2006 1.13
12 Mevalonate kinase deficiency: Evidence for a phenotypic continuum. Neurology 2004 1.08
13 Treatment extension benefits HCV genotype 1 patients without rapid virological response: a systematic review. Neth J Med 2011 1.04
14 On-demand anakinra treatment is effective in mevalonate kinase deficiency. Ann Rheum Dis 2011 1.04
15 Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis 2006 1.01
16 Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Aliment Pharmacol Ther 2007 1.00
17 [Serious complications following (removal after) ingestion of a partial denture]. Ned Tijdschr Tandheelkd 2008 1.00
18 Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 2005 0.99
19 Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review. Neth J Med 2007 0.98
20 A case of esophageal duplication cyst with a 13-year follow-up period. Endoscopy 2005 0.96
21 Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes. Rheumatology (Oxford) 2005 0.94
22 Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C. Aliment Pharmacol Ther 2011 0.90
23 High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: a case report and brief review of literature. Neth J Med 2013 0.88
24 CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis. Dig Liver Dis 2006 0.87
25 Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases. J Med Genet 2005 0.86
26 Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent. Aliment Pharmacol Ther 2006 0.86
27 Prevalence of hepatitis C in the general population in the Netherlands. Neth J Med 2008 0.85
28 Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency. Clin Exp Immunol 2009 0.84
29 FDG-PET scanning in the diagnosis of gastrointestinal cancers. Scand J Gastroenterol Suppl 2004 0.83
30 Effect of inflammatory attacks in the classical type hyper-IgD syndrome on immunoglobulin D, cholesterol and parameters of the acute phase response. J Intern Med 2004 0.82
31 Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum. Neth J Med 2011 0.81
32 Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome. Amyloid 2005 0.81
33 [A Dutch family with the hereditary periodic fever or tumour necrosis factor receptor-associated periodic syndrome (TRAPS)]. Ned Tijdschr Geneeskd 2007 0.80
34 Chronic yersiniosis due to defects in the TLR5 and NOD2 recognition pathways. Neth J Med 2010 0.80
35 [Serious complications following removal of an ingested partial denture]. Ned Tijdschr Geneeskd 2007 0.80
36 Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis. Rheumatology (Oxford) 2008 0.80
37 Systematic review: the management of hepatic cyst infection. Aliment Pharmacol Ther 2014 0.80
38 Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients. J Viral Hepat 2010 0.79
39 Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Infect 2005 0.79
40 Lovastatin inhibits formation of AA amyloid. J Leukoc Biol 2008 0.78
41 Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era. Neth J Med 2014 0.78
42 Clinical features of liver involvement in adult patients with listeriosis. Review of the literature. Infection 2007 0.77
43 Genetic basis of chronic pancreatitis. Scand J Gastroenterol Suppl 2002 0.77
44 AL amyloidosis enhances development of amyloid A amyloidosis. Br J Dermatol 2007 0.77
45 The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection. Neth J Med 2012 0.77
46 Treatment of hepatitis C monoinfection in adults--Dutch national guidelines. Neth J Med 2013 0.77
47 Genetic heterogeneity and exclusion of a modifying locus at 2q in a family with autosomal dominant primary erythermalgia. Br J Dermatol 2005 0.76
48 Hepatitis C virus infection management in 2012. Panminerva Med 2012 0.76
49 Hyperimmunoglobulinaemia D syndrome in India: report of two siblings with a novel mutation. Ann Rheum Dis 2006 0.76
50 Catechol-O-methyltransferase (COMT) gene variants and pain in chronic pancreatitis. Neth J Med 2011 0.76
51 Comment on: How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects? Dig Liver Dis 2009 0.76
52 [Three women with autoimmune hepatitis: the clinical importance of early diagnosis and remission]. Ned Tijdschr Geneeskd 2006 0.75
53 Absence of an association of the IBD2 locus gene keratin 8 and inflammatory bowel disease in a large genetic association study. Dig Liver Dis 2004 0.75
54 [Liver abscesses as a complication of Crohn's disease]. Ned Tijdschr Geneeskd 2005 0.75
55 Rationale and design of the virological response and ribavirin dosage (VIRID) study in hepatitis. Neth J Med 2008 0.75
56 Hepatosplenic schistosomiasis: a review. East Afr Med J 2004 0.75
57 [From gene to disease; hepatocystin and autosomal dominant polycystic liver disease]. Ned Tijdschr Geneeskd 2003 0.75
58 UGT1A7 polymorphisms in chronic pancreatitis: an example of genotyping pitfalls. Pharmacogenomics J 2007 0.75
59 [Dutch study on the optimal treatment strategy for patients with a first or second occurrence of gastro-oesophageal variceal bleeding: the TIPS-TRUE trial]. Ned Tijdschr Geneeskd 2008 0.75
60 How the concept of biochemical response influenced the management of primary biliary cholangitis over time. Neth J Med 2016 0.75
61 Current clinical care compared with new Dutch guidelines for hepatitis C treatment. Neth J Med 2009 0.75
62 [Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias]. Ned Tijdschr Geneeskd 2006 0.75
63 The Netherlands Journal of Medicine's hit list: best cited articles in 2003. Neth J Med 2005 0.75
64 [New drugs available more quickly for the right patient]. Ned Tijdschr Geneeskd 2016 0.75